Tesamorelin 10MG is a lyophilized research compound for controlled in vitro endocrine and biochemical research. Batch-specific analytical verification accompanies applicable shipments.
Original price was: $ 160.$ 149Current price is: $ 149.
Tesamorelin 10MG is a synthetic research compound supplied as lyophilized powder for controlled in vitro laboratory research. It is positioned within BioPeak USA’s molecular research materials for qualified facilities conducting biochemical and endocrine pathway investigations.
Applicable production batches undergo analytical verification for product identity and purity. High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry provide analytical characterization, while batch-specific Certificate of Analysis (CoA) documentation records the relevant findings.
Tesamorelin 10MG is a research-grade biochemical material supplied in a 10MG lyophilized format. It is classified as Research Use Only (RUO) and is intended exclusively for qualified laboratory personnel conducting controlled scientific investigations.
Within laboratory research, Tesamorelin may be examined in studies involving endocrine pathways, peptide-related research models, and biochemical signaling investigations. Product-specific research applications should be determined by qualified researchers according to their laboratory objectives and established procedures.
Product Name: Tesamorelin 10MG
CAS Number: 218949-48-5
Product Format: 10MG lyophilized powder per vial
Purity: ≥99%, where supported by applicable batch testing
Analytical Methods: HPLC and Mass Spectrometry
Additional Analysis: ESI-MS and Karl Fischer Titration where applicable
Certificate of Analysis: Batch-specific CoA documentation
Tesamorelin product is intended for in vitro laboratory research involving endocrine and biochemical models. Research facilities may examine the material in investigations involving signaling pathways, peptide-related laboratory studies, and analytical research workflows.
The material can also serve as a laboratory reference compound where documented identity, analytical purity, and batch-level information are important for controlled research environments.
Tesamorelin should be handled according to the applicable product documentation and the research facility’s established Standard Operating Procedures (SOPs).
For unopened lyophilized material, follow the storage requirements stated in the applicable product documentation or batch-specific CoA. Where −20°C is specified, maintain the sealed material at −20°C and protect it from unsuitable environmental conditions.
Where laboratory preparation is required, qualified personnel should follow validated facility procedures and applicable product documentation.
Every applicable Tesamorelin batch undergoes analytical quality assessment before release. HPLC is used for analytical purity assessment, while Mass Spectrometry and Electrospray Ionization Mass Spectrometry (ESI-MS) provide additional product characterization.
Karl Fischer Titration may be used to determine residual moisture where specified by the applicable batch documentation. Relevant analytical findings are recorded in the corresponding Certificate of Analysis.
Tesamorelin 10MG is supported by batch-level analytical documentation designed to provide traceability for qualified research facilities. Applicable shipments include a batch-specific Certificate of Analysis containing relevant product and analytical information.
Additional technical documentation may be available through the BioPeak USA Technical Operations team upon request.
Tesamorelin 10MG is supplied exclusively for laboratory and scientific research and is classified as Research Use Only (RUO).
It is not intended for human use, veterinary use, clinical application, or therapeutic purposes. Handling should be limited to qualified laboratory personnel following applicable institutional policies, laboratory procedures, and regulatory requirements.
Q: What is Tesamorelin 10MG?
A: Tesamorelin 10MG is a lyophilized research compound supplied for controlled in vitro laboratory investigations involving endocrine, biochemical, and peptide-related research models.
Q: What is Tesamorelin 10MG used for in research?
A: Tesamorelin 10MG is intended for laboratory research involving endocrine pathways, biochemical investigations, signaling models, and analytical research workflows.
Q: Is Tesamorelin 10MG Research Use Only?
A: Yes. Tesamorelin 10MG is classified as Research Use Only (RUO) and is intended for qualified laboratory and scientific research.
Q: How is Tesamorelin 10MG analytically verified?
A: Applicable batches are assessed using HPLC and Mass Spectrometry. Additional analytical methods may be documented in the applicable batch-specific CoA.
Q: Does Tesamorelin 10MG include a Certificate of Analysis?
A: Yes. Applicable batches are supplied with a batch-specific Certificate of Analysis containing relevant product identity and analytical findings.
Q: What purity standard does Tesamorelin 10MG meet?
A: Applicable production batches are documented at ≥99% purity where supported by the corresponding analytical testing results.
Q: How should Tesamorelin 10MG be stored?
A: Follow the storage requirements provided in the applicable product documentation or batch-specific CoA. Where −20°C is specified, unopened lyophilized material should be maintained at −20°C.
Tesamorelin 10MG is a lyophilized research compound designed for controlled in vitro laboratory investigations involving endocrine and biochemical research models. Analytical verification through HPLC and Mass Spectrometry, together with batch-specific Certificate of Analysis documentation, provides research facilities with documented product information and batch traceability.
BioPeak USA maintains a research-focused approach centered on analytical documentation, quality assessment, and Research Use Only positioning. Qualified research facilities can contact the Technical Operations team for applicable batch-specific documentation and technical information.
